chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm soreness; Huge headache; Low grade fever (99.5); Felt cold, couldn't get warm; chills; Stabbing, shooting pain in right parotid glands; General feeling of unwellness; This is a spontaneous report from a contactable nurse. A 54-years-old female patient started to the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot EL0142, on 06Jan2021 (at the age of 54-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included chronic granulomatous disease. Concomitant medication were unspecified. The patient previously received the  first dose of BNT162B2, Lot number: EK5730, on 17Dec2020, administration time: 08:00 AM, in the left arm for covid-19 immunization. The patient previously took Oxacillin and Levaquin and experienced allergies. The most recent COVID-19 vaccine was administered in the workplace clinic. The patient was not pregnant at the time of vaccination.   Prior to vaccination, the patient was not diagnosed with COVID-19. On 07Jan2021 09:30, the patient experienced arm soreness, huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellnessThe events arm soreness, Huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellness did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the events. Outcome of the events arm soreness, Huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellness was recovered. Since the vaccination, the patient has not been tested for COVID-19.
Patient received booster dose (0.25 ml) of monovalent on September 9th 2022, which was after August 31st, 2022.  Follow up call was made to the patient and no adverse event was reported.  Patient was informed that she can get the new bivalent booster dose after two months from the last time she received the monovalent booster.
body aches; headache; fatigue; This is a spontaneous report from a non-contactable pharmacist (consumer). A 16-years-old patient of an unspecified gender received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported), via an unspecified route of administration on an unspecified date as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 for covid-19 immunisation . On an unknown date, about 5 hours after the injection, the patient experienced body aches, headache and fatigue which lasted for about 24 hours. The patient was given Tylenol for the events. The outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient first received MENACTRA in right arm without issues, placed tdap in left arm when patient had a vasovagul response and passed out. Mom laid patient down on exam table and patient gain conscious after a few seconds. Patient was pale and diaphoretic. Elevated patients legs. Took BP 82/52. Had patient drink apple juice while laying down. Took BP again 6:23 pm 60/60. 6:25 PM patient sat up on exam table, BP 102/62. 6:35 pm patient was able to ambulate out of clinic with mom, without any complaints of dizziness or lightheadedness.
My 65 year old, generally healthy mother received a VACCINATION for SHINGLES & a Pneumonia VACCINATION (simultaneously & referred to as the Pneumo Vac per her doctor) on September 10, 2007 & I took her back to the doctor's office 10/02/07 with Shingle-like-symptoms. She was told @ the time of the vaccinations that they were NEW & made by MERCK & that her doctor chose 30 patients to try the dual vaccinations out on.  My mother is ill now & we had x-rays done yesterday & the doctor said it is arthiritis & nothing to do with Shingles, we go back Monday 10/08/07 & we are insisting on a Shingles blood test because she was not ill PRIOR to this vaccination.
This is a spontaneous report from a contactable consumer reporting on herself.  A 71-year-old female patient received PREVNAR 13, via an unspecified route of administration on 21Dec2016 at 11:00 at a single dose in the left arm for immunisation. Medical history included ongoing borderline diabetes for about 5 years, ongoing high blood pressure for about 10 years ago, ongoing diverticulitis for about 8-9 years for which she had surgery for about 6 years ago; high cholesterol, reflux, and inflammation. Concomitant medications included pravastatin, omeprazole, metformin, hydrochlorothiazide/lisinopril, ergocalciferol, curcuma longa rhizome, and zingiber officinale rhizome. On 21Dec2016, the patient couldn't move her left arm, couldn't lay on her left side because it was painful, and had pain in the left hand. The clinical course was as follows: About 2 hours after receiving the vaccine, she couldn't move her left arm. She took ALEVE and alternated heat and cold to area. The next day, 22Dec2016, it was better but she still couldn't raise her arm. She couldn't lay on her left side because it was so painful. She called her doctor's office about what she was experiencing and was told to continue doing what she was doing as it had improved slightly at that time. After a few days, she called her doctor again and explained she was still having problems. They recommended she go to the urgent care. A physician assistant at the urgent care prescribed prednisone 20mg daily for 4 days. The prednisone immediately helped. She could finally move her left arm and was moving it quite well but couldn't lift it above her head. She reported the pain was relatively gone and she was able to cut back on the naproxen sodium. But still had pain in her left hand and thus she could not use her left hand. She could barely squeeze a ball and couldn't write very well as she was left handed. The clinical outcome of the events, vaccination site joint movement impairment, was recovering. The clinical outcome of the pain in the left hand, was not recovered. The clinical outcome of the event, pain on the left side, was unknown.
First dose on 20-March-2021 and Second dose on 17-Sep-2021; Flu like symptoms; Headache; Body ache; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), MYALGIA (Body ache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 20-March-2021 and Second dose on 17-Sep-2021) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 04382H and 237192B) for COVID-19 prophylaxis.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for Multiple sclerosis.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 20-March-2021 and Second dose on 17-Sep-2021). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache) and MYALGIA (Body ache). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache) and MYALGIA (Body ache) had resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 20-March-2021 and Second dose on 17-Sep-2021) outcome was unknown.            Patient reported that after a day of receiving vaccines she experienced flu like symptoms including headache and body ache and it was resolved after a day.   No treatment information was provided by the reporter.
Red Eyes; feels like grit in eyes; This is a spontaneous report from a contactable consumer (patient).   A 74-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot: EL9262), via an unspecified route of administration, administered in left arm on 11Feb2021 at 09:30 (at the age of 74 years-of-old) at single dose for COVID-19 immunisation. The Patient Medical history were none. The concomitant medications were not reported. The patient had no known allergies. The patient did not receive any other vaccine in 4 weeks. The patient did not have COVID-19 prior or post vaccination. On 12Feb2021 at 08:00 AM, patient experienced red eyes and felt like grit in eyes. The events resulted in emergency room/department or urgent care. It is unknown if the treatment was given. Patient took other unspecified medications in two weeks. The patient did not take any other vaccine in four weeks. The patient not had COVID prior vaccination and not tested for COVID post vaccination. The outcome of the events was not recovered.
About ten minutes after the shot I had tightness of the chest and difficulty breathing, An hour later nausea and dizziness. Later that day I experienced muscle aches and joint pain, teeth started to hurt on the right side and jaw was hurting.
First shot had a sore/pain in left shoulder in the joint which lasted 2 to 3 days. Second shot: 5-22-21 in right arm. next day headache 2 days, and two three days later started having pain in both shoulders and arms with weakness and numbing in both hands and pain in butt muscles down to calves.
From pediatrician records, on 6/25, 5 days after vaccinations of 6/20, patient experienced up and down fevers of 101F, loss of appetite, lethargy, and sleepiness which persisted for 6 to 7 days.  This was patient's first life illness.  Patient later suffered permanent hearing loss which may or may not be the result of this adverse event.
hypoplastic anemia;bone marrow biopsy revealed 30-40% cellularity;no megakaryocytes;very depressed myeloid & mod depressed erythroid lines;
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; SHINGLES ON HIS ARM; This spontaneous report received from a patient concerned a 70 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered on 04-DEC-2021 to left arm for prophylactic vaccination. Age at time of vaccination 69 years old. The batch number was not reported and has been requested. No concomitant medications were reported. The patient had taken only primary dose. On an unspecified date in JUN-2022 after the shot (6 months or more), the patient got a rash caused by the virus of chickenpox on his left arm (shingles). He said it went away and came back. On 29-JUN-2022, the patient experienced confirmed covid-19 infection and had confirmed clinical vaccination failure. The patient reported that he was knocked out and had the symptoms of cold sweats, fever, cough, and felt like he was on death's door. He was feeling better at the time of reporting with a bit of flu-like symptoms left, real mild now. He did not went to work yet. Laboratory data included: COVID-19 antigen test Positive at home. On 12-JUL-2022, Laboratory data included: COVID-19 antigen test Positive at home. The patient had not visited to any doctor. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure and shingles on his arm was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint.; Sender's Comments: V0: 20220726100-COVID-19 VACCINE AD26.COV2.S-confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Information has been received from a nurse concerning a female patient with yeast allergy resulted in hives who was vaccinated with the second dose of GARDASIL (lot number and route of administration not reported). There was no concomitant medication. The patient experienced severe pain in her left deltoid. The pain lasted 3 days and she was unable to raise her arm and she was in tears. She had no problems after the first dose of GARDASIL. The patient went to her physician's office. No further information is available.
pt recv vax & was  positive for hepatitis B surface antigen & still is;pt believes this diagnostic result is from the vax & not other factors;
strong metallic taste in my mouth; dry mouth; bedridden; chills; body aches; arthralgia; stomach pain; nausea; tiredness; sleepless; loss of appetite; could not hydrate; exhausted; weight loss; night sweats; weakness; This spontaneous case was reported by a physician and describes the occurrence of DYSGEUSIA (strong metallic taste in my mouth), DRY MOUTH (dry mouth), BEDRIDDEN (bedridden), CHILLS (chills) and PAIN (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VALSARTAN (DIOVAN), LEVOTHYROXINE SODIUM (SYNTHROID), PANTOPRAZOLE, ATORVASTATIN, METOPROLOL and COLECALCIFEROL (VIT D3) for an unknown indication.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DYSGEUSIA (strong metallic taste in my mouth), DRY MOUTH (dry mouth), BEDRIDDEN (bedridden), CHILLS (chills), PAIN (body aches), ARTHRALGIA (arthralgia), ABDOMINAL PAIN UPPER (stomach pain), NAUSEA (nausea), FATIGUE (fatigue), FATIGUE (tiredness), INSOMNIA (sleepless), DECREASED APPETITE (loss of appetite), DEHYDRATION (could not hydrate), FATIGUE (exhausted), WEIGHT DECREASED (weight loss), NIGHT SWEATS (night sweats) and ASTHENIA (weakness). At the time of the report, DYSGEUSIA (strong metallic taste in my mouth), DRY MOUTH (dry mouth), BEDRIDDEN (bedridden), CHILLS (chills), PAIN (body aches), ARTHRALGIA (arthralgia), ABDOMINAL PAIN UPPER (stomach pain), NAUSEA (nausea), FATIGUE (fatigue), FATIGUE (tiredness), INSOMNIA (sleepless), DECREASED APPETITE (loss of appetite), FATIGUE (exhausted), WEIGHT DECREASED (weight loss), NIGHT SWEATS (night sweats) and ASTHENIA (weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: normal (normal) normal. On an unknown date, Endoscopy: normal (normal) nothing significant.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   action taken with MRNA-1237 in response to the events wasn't applicable multivitamin is also included as concomitant drug
she had bad diarrhea after her first covid vaccine/She says a nurse she spoke to had a similar reaction; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "she had bad diarrhea after her first covid vaccine/She says a nurse she spoke to had a similar reaction". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Body Aches Generalized-Mild, Systemic: Fever-Medium
Breakthrough case admission after three vaccines Moderna 3/7/21 Lot# 010A21A;  Moderna 4/3/21 Lot# 015B21A;  Moderna 12/10/21 Lot# 032H21A
I have a rash, that start 28May. It really only flare up in the morning when I wake up and at night before going to bed; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: ER8736), via an unspecified route of administration, administered in arm left on 21May2021 15:30 as dose 1, single (at the age of 37-year-old) for covid-19 immunization. The patient was non-pregnant at the time of vaccination. Medical history reported as none. There were no known allergies. Concomitant medication included mepyramine maleate, pamabrom, paracetamol (PAMPRIN). On 28May2021 06:00, the patient experienced rash. It really only flares up in the morning when she wakes up and at night before going to bed. It started on her hands, then ankles now it was on her arms, neck and face. The patient did not receive any treatment for the events. The patient did not received any other vaccine in four weeks. The patient had not covid prior to the vaccination and patient had not tested for covid post vaccination. The outcome of the event was not recovered.   Follow-up attempts were completed. No further information was expected.
LIGHTHEADED, DIZZINESS, FUSSY VISION, PROVIDED WATER/SNACK, SX RESOLVED, NO TRANSPORT
I had severe dizziness one week following my first COVID vaccine on 9-8-21.  I did enter a report following that incident. I then was feeling somewhat better and had to receive my 2nd COVID vaccine. I received that on 9-29-21. Since that day I have been experiencing dizziness daily. At times I feel like my whole self is spinning (especially while first lying down in bed at night). Other times I cannot walk a straight line and feel fuzzy in my head. Have to hang onto walls when walking.  I did not have these types of sensations prior to receiving the COVID vaccines.
Client c/o pain to site, and swelling to shoulder blade area. Palpable lymph node.
Headache, Myalgia, Fever, stiff neck, fatigue Narrative: N/A
Day of vaccine, had pain at injection site. Day after second vaccine, had mild headache, body aches and exhaustion. No symptoms between days 3 and 8. Day 9 after second vaccine, severe headache (pressure in a band around head, both temples and base of head) and mild nausea.
I was diagnosed with low tension Glaucoma. They have given me a drug called ALPHAGAN 0.1% eye drops that lowers my eye tension even more. My vision is much better now. In theory if I take these drops for the rest of my life it won't get any worse.
About 1 hour, post vax, the reaction got progressively worse, with erythema, warmth and swelling with extending induration of over 2/3 circumference of posterior upper left arm from axilla to elbow. Pt also stated, she experienced vision change and difficulty in seeing distance with each vaccinations. She stated she had a headache, dry eyes and required new glasses after her 3rd shot. She was treated with Tylenol, ice packs and prescription for acetaminophen 325mg.
Shingles; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12May2023 at 19:00 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization. The following information was reported: HERPES ZOSTER (non-serious) with onset 14May2023, outcome "not recovered", described as "Shingles". Therapeutic measures were taken as a result of herpes zoster.  Additional information: Was diagnosed with shingles officially yesterday on 15May2023. However, the outbreak started on Sunday 14May2023. The time the outbreak started was unknown. The outbreak occurred on her right buttocks. She mentioned her husband also got the same shot and had no reaction. She has had all the previous Covid 19 Vaccines and this was the next one. The only thing was when she got the second singles shot she also got shingles and it was in the same location. Reporter declined to continue to complete report. Stated she had made it to her destination and had to go.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Patient presented to the hospital with fever and was found to have COVID. Had fever and congestion a week prior. Given 2L NC and steriods.
Patient given PNEUMOVAX shot Friday 12-2-11 at approximately 10:40 AM. Patient came to store today 12-6-11 to inform me that she has pain from shot that lasted until Sunday 12-4-11. She also experienced swelling in left arm & redness. She is doing better today.
Patient developed an allergic reaction which included lip swelling and facial swelling around the eyes.  Symptoms resolved after coming to the ED and receiving Benadryl, solumedrol, and epinephrine.
Within two weeks-leg pain, chest pain, abdominal cramps, headache and nausea
CHILD'S DATE OF BIRTH WRITTEN WRONG AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY PERSON IDENTIFYING AS MOTHER. CHILD IDENTIFIED IN DATABASE WITH CORRECT DATE OF BIRTH. CHILD IS TOO YOUNG TO RECEIVE VACCINE.
This spontaneous report was received from a pharmacist referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapy were not provided. On multiple unspecified dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX injection (lot# reported as M035695 expiration date 07-NOV-2017 and lot# reported as M034764 expiration date 26-OCT-2017) for prophylaxis (strength, dose and route were not provided). The vaccines were exposed to a temperature excursion between 14 Fahrenheit degrees and 46 Fahrenheit degrees for 2 hours. The call was placed because of a Digital data logger. No previous temperature excursion and no adverse effects were reported. Additional information has been requested.
Information has been received from a pharmacist concerning a patient of unknown age and gender. On 16-AUG-2013, the patient was vaccinated with the first dose of GARDASIL (dose, route, lot number and expiration date were unspecified). The pharmacist reported that patient was in pharmacy received the second dose of GARDASIL on 08-JUL-2015 (Inappropriate schedule of vaccine administered). No adverse effects were reported. Additional information has been requested.
Information has been received through the pregnancy registry for GARDASIL from a health professional concerning a 16 year old adopted female who in November 2007 was vaccinated with the second dose of GARDASIL. Per the reporter, the patient may have been pregnant when she was given her second dose of GARDASIL (LMP=01-NOV-2007). No adverse events were reported and no further information was available. Follow up information was received which reported that the routine obstetric labs were normal and the first and second trimester metabolic panel screens were within normal limits. On 25-FEB-2008 the patient's PAP smear was abnormal: "epithelial cell, abnormality squamous: low grade squamous intraepithelial lesions. HPV changes, possible CIN1." Repeat Pap smear will be performed in 6 months. During pregnancy and labor, the patient had preeclampsia. The patient was treated with magnesium sulfate. On 16-JUl-2008 the patient delivered a baby boy at 36.4 weeks gestation. The infant's weight was 5lb 10oz. The infant was normal and no congenital abnormalities. Additional information is not expected.